Fortrea

Fortrea is a global Contract Research Organization (CRO) with over 30 years of clinical development expertise. The company delivers comprehensive Phase I through Phase IV study management, clinical pharmacology services, and market access solutions to biopharma, biotech, and MedTech companies worldwide.

Core Service Offerings

Clinical Development: Fortrea provides end-to-end clinical trial management across all phases, including Phase I units with in-clinic cGMP pharmacies, mobile clinical services, and digital health solutions. The company offers clinical pharmacology services, electronic data capture, clinical trial data visualization, and specialized consulting for renal and hepatic impairment studies.

Data & Analytics: Services include clinical trial data management, biostatistics and statistical programming, electronic data capture (EDC), and clinical trial data visualization capabilities.

Safety & Regulatory: The organization provides safety services, medical writing, pharmacovigilance operations, and regulatory strategy consulting. Fortrea was named a leader in Pharmacovigilance Operations in the PEAK Matrix Assessment 2025.

Specialized Solutions: The company offers market access and health economics outcomes research (HEOR), patient-centered endpoints (PaCE) development, and real-world evidence (RWE) and post-approval studies. Fortrea has formed a strategic collaboration with SCTbio to advance cell and gene therapy development, combining clinical expertise with cGMP manufacturing capabilities.

Delivery Models: Fortrea operates as both a full-service outsourcing (FSO) partner and functional service provider (FSP). The company's proprietary Fortrea Intelligent Technology™ (FIT) platform includes FIT Lifecycle Solutions, FIT Foresight Solutions, and FIT Companion Solutions to enable faster decision-making and streamlined study delivery.

Therapeutic Expertise

Fortrea supports development across multiple therapeutic areas including cardiovascular, cell and gene therapies, diabetes and endocrinology, dermatology, hematology, hepatology, infectious disease and vaccines, inflammatory and autoimmune conditions, nephrology, neuroscience, obesity, oncology, ophthalmology, pediatrics, rare diseases, respiratory and pulmonology, and women's health.

Global Presence

The organization operates in approximately 100 countries with offices across Africa, the Americas, Asia Pacific, and the Middle East, providing expert support and local presence for clinical development programs worldwide.